Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fuchs heterochromic cyclitis: current concepts].

E Bloch-Michel

    Journal Francais D'Ophtalmologie
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Fuchs' heterochromic cyclitis (FHC) is a rare uveitis subtype, often challenging to diagnose early due to variable symptoms and atypical presentations. Research explores immune complexes and iris vascular anomalies, suggesting a congenital predisposition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tear IgE detected by a new method: Stallerdiag-IgE.

    Ocular immunology and inflammation·2012
    Same author

    [Rhinoconjunctivitis: importance of a local diagnosis?].

    European annals of allergy and clinical immunology·2004
    Same author

    Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.

    European journal of ophthalmology·2001
    Same author

    Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.

    The British journal of ophthalmology·1999
    Same author

    Multiple sclerosis associated with uveitis in two large clinic-based series.

    Neurology·1999
    Same author

    Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.

    European journal of ophthalmology·1999
    Same journal

    Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

    Journal francais d'ophtalmologie·2026
    Same journal

    [Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

    Journal francais d'ophtalmologie·2026
    Same journal

    Sequential dexamethasone and fluocinolone acetonide intravitreal implants to treat macular edema in non-infectious uveitis.

    Journal francais d'ophtalmologie·2026
    Same journal

    Intravitreal anti-VEGF therapy: Comparative evaluation of appropriateness and readability of large language model chatbots' responses to frequently asked patient questions.

    Journal francais d'ophtalmologie·2026
    Same journal

    [Trabecular surgeries in the management of glaucoma: A review of literature].

    Journal francais d'ophtalmologie·2026
    Same journal

    Cataract surgery in eyes with nanophthalmos: Operative technique and refractive outcomes - A case series.

    Journal francais d'ophtalmologie·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Immunology

    Context:

    • Fuchs' heterochromic cyclitis (FHC) is a rare condition, comprising 1-2% of uveitis cases.
    • Early diagnosis is often difficult due to incomplete or atypical forms.
    • Heterochromia can be challenging to detect in individuals with brown eyes.

    Purpose:

    • To review the clinical features, diagnostic challenges, and current understanding of Fuchs' heterochromic cyclitis.
    • To explore paraclinical findings, including immunological techniques and fluoroangiography.
    • To discuss potential etiological factors, such as congenital predisposition.

    Summary:

    • FHC presents with variable onset of cataract, heterochromia, and cyclitis.
    • Immune complexes in aqueous humor and iris vascular anomalies are frequently observed.

    Related Experiment Videos

  • Diagnosis is complicated by atypical presentations and difficulty in identifying heterochromia.

    • Impact:

    • Highlights the diagnostic difficulties and limited paraclinical tools for FHC.
    • Suggests immune mechanisms and vascular changes are key features.
    • Underscores the need for further research to elucidate the etiology and develop diagnostic strategies.